Andries M. Bergman
Oncode Institute(NL)Amsterdam University Medical Centers(NL)University of Amsterdam(NL)Amsterdam UMC Location Vrije Universiteit Amsterdam(NL)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Mathematical Biology Tumor Growth, Radiopharmaceutical Chemistry and Applications, Cancer Immunotherapy and Biomarkers, Cancer, Lipids, and Metabolism
Most-Cited Works
- → Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial(2014)1,480 cited
- → Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)(2002)351 cited
- Interaction between cisplatin and gemcitabine in vitro and in vivo.(1995)
- Synergistic interaction between cisplatin and gemcitabine in vitro.(1996)
- → Basis for effective combination cancer chemotherapy with antimetabolites(2000)292 cited
- → Prostate cancer reactivates developmental epigenomic programs during metastatic progression(2020)280 cited
- → Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1(2016)244 cited